A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
Aliment Pharmacol Ther
; 21(4): 373-84, 2005 Feb 15.
Article
in En
| MEDLINE
| ID: mdl-15709987
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gastrointestinal Agents
/
Crohn Disease
/
Anti-Inflammatory Agents, Non-Steroidal
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Aliment Pharmacol Ther
Journal subject:
FARMACOLOGIA
/
GASTROENTEROLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2005
Type:
Article
Affiliation country:
Canada